Julie Jordan - Net Worth and Insider Trading

Julie Jordan Net Worth

The estimated net worth of Julie Jordan is at least $389 dollars as of 2024-11-05. Julie Jordan is the Chief Medical Officer of Homology Medicines Inc and owns about 416 shares of Homology Medicines Inc (FIXX) stock worth over $389. Details can be seen in Julie Jordan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Julie Jordan has not made any transactions after 2023-08-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Julie Jordan

To

Julie Jordan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Julie Jordan owns 1 companies in total, including Homology Medicines Inc (FIXX) .

Click here to see the complete history of Julie Jordan’s form 4 insider trades.

Insider Ownership Summary of Julie Jordan

Ticker Comapny Transaction Date Type of Owner
FIXX Homology Medicines Inc 2023-08-03 Chief Medical Officer

Julie Jordan Latest Holdings Summary

Julie Jordan currently owns a total of 1 stock. Julie Jordan owns 416 shares of Homology Medicines Inc (FIXX) as of August 3, 2023, with a value of $389.

Latest Holdings of Julie Jordan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FIXX Homology Medicines Inc 2023-08-03 416 0.93 389

Holding Weightings of Julie Jordan


Julie Jordan Form 4 Trading Tracker

According to the SEC Form 4 filings, Julie Jordan has made a total of 2 transactions in Homology Medicines Inc (FIXX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Homology Medicines Inc is the sale of 103 shares on August 3, 2023, which brought Julie Jordan around $2,576.

Insider Trading History of Julie Jordan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Julie Jordan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Julie Jordan Ownership Network

Ownership Network List of Julie Jordan

No Data

Ownership Network Relation of Julie Jordan

Insider Network Chart

Julie Jordan Owned Company Details

What does Homology Medicines Inc do?

Who are the key executives at Homology Medicines Inc?

Julie Jordan is the Chief Medical Officer of Homology Medicines Inc. Other key executives at Homology Medicines Inc include director & President & CEO Arthur Tzianabos , See Remarks Paul Alloway , and Chief Scientific Officer Albert Seymour .

Homology Medicines Inc (FIXX) Insider Trades Summary

Over the past 18 months, Julie Jordan made 2 insider transaction in Homology Medicines Inc (FIXX) with a net sale of 1,952. Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 13,037 shares made by Arthur Tzianabos , a net sale of 7,280 shares made by Paul Alloway , and a net sale of 1,708 shares made by .

In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,413 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,413 shares.

Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Homology Medicines Inc Insider Transactions

No Available Data

Julie Jordan Mailing Address

Above is the net worth, insider trading, and ownership report for Julie Jordan. You might contact Julie Jordan via mailing address: C/o Homology Medicines, Inc., One Patriots Park, Bedford Ma 01730.